● Recruiting

High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC)

Condition: Carotid Artery Disease · Symptomatic Carotid Artery Stenosis · Carotid Artery Stenting · Sponsor: Acandis GmbH

PhaseN/A

Planned participants536

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

Goal is to analyse the clinical safety and efficacy of the CARESTO® heal Stent within standard clinical routine for the treatment of patients with symptomatic non-stenotic carotid disease (SyNC) and with high-risk plaque features for stroke recurrence compared to medical treatment alone with respect to the mid- and long-term clinical outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Acandis GmbH · +49 (0) 7231 - 155 00 171 · info@acandis.com

Always discuss trial participation with your own doctor first.

Locations (1)

Städtisches Klinikum Solingen

Solingen, North Rhine-Westphalia, Germany

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07166731